Search results
Katalin " Kati " Karikó ( Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American [2] biochemist who specializes in ribonucleic acid ( RNA )-mediated mechanisms, particularly in vitro - transcribed messenger RNA (mRNA) for protein replacement therapy. [3]
Katalin Karikó. BioNTech RNA Pharmaceuticals. Verified email at upenn.edu. mRNA-based therapy for protein replacement.
Katalin Karikó. The Nobel Prize in Physiology or Medicine 2023. Born: 17 January 1955, Szolnok, Hungary. Affiliation at the time of the award: Szeged University, Szeged, Hungary; University of Pennsylvania, Philadelphia, PA, USA.
Interview with the 2023 Nobel Prize laureate in physiology or medicine Katalin Karikó on 6 December 2023 during the Nobel Week in Stockholm, Sweden. Read the interview.
Oct 2, 2023 · Press release 2023-10-02 The Nobel Assembly at Karolinska Institutet has today decided to award the 2023 Nobel Prize in Physiology or Medicine jointly to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19
Katalin Karikó (born January 17, 1955, Kisújszállás, Hungary) is a Hungarian-born biochemist known for her pioneering research into RNA (ribonucleic acid) therapeutics, particularly the development of messenger RNA (mRNA) vaccines.
Katalin Karikó, PhD, is a biochemist and researcher, best known for her contributions to mRNA technology and the COVID-19 vaccines. Karikó and Drew Weissman, MD, PhD, were jointly awarded the 2023 Nobel Prize in Medicine for their discoveries that enabled the modified mRNA technology used in Pfizer-BioNTech and Moderna’s vaccines to prevent ...
